Thursday, December 04, 2025

Countable Labs: New Approach to Enumerating DNA

Countable Labs, formerly Enumerix, was founded by serial entrepreneur Stephen Fodor, who originally stormed on the molecular tools scene with Affymetrix.  I caught up with their new CEO, Giovanna Prout, at ASHG the other week and got a rundown on their new approach to counting molecules with PCR.


Prout recently found herself out of the CEO job at Scale Biosciences after its acquisition by 10X Genomics.  She says she resolved to become the best stay-at-home mother ever and her kids loved having her home - but soon urged her to find a new gig as they recognized it was what made her happiest.  So she quickly landed the CEO role at Countable Labs.  Formerly Enumerix, the company is yet another molecular tools company from prolific scientific entrepreneur Stephen Fodor, best known for Affymetrix.


Countable’s standard workflow is simple.  A 50 microliter reaction of sample DNA, probes, primers, PCR mastermix, and Countable’s proprietary matrix consumable are placed in a spin column.  Centrifuging the columns generates a matrix, with approximately 30M individual picoliter-scale compartments capturing individual DNA molecules.  After a brief (60 minute) PCR amplification in a conventional thermocycler (Countable has a list of preferred instruments), the tubes are placed in Countable’s benchtop instrument for light sheet microscopy imaging of the compartments, requiring 5 minutes of imaging per tube.  There’s no dead volume - every picoliter scale chamber in the tube will be imaged.  Because there are so many compartments, the system has a dynamic range of 6 logs!  Countable’s instrument holds 96 tubes in the form of 24 strips of 4 tubes each.  The instrument is priced at $150K with consumables adding up to $16 per sample. A full set of 96 samples can be processed in half a workday.





Assays can be designed using Countable’s universal multiplexing kit or conventional TaqMan hydrolysis probes can be included.  The universal multiplexing kit has the advantage of enabling the use of inexpensive, fast arriving ordinary oligos which simply require a 5’ tail sequence on the forward primer to enable linking (via primer extension) the universal multiplexing codes to the user primers.  Countable provides a software tool to streamline converting existing assays into universal multiplexing assays and analyze the resulting multiplex primer designs for undesirable cross-reactivity. Assays based on the universal multiplexing kit can be designed and tested in under a week


Countable is developing a high degree of multiplexing by managing the optical system so that it is capable of distinguishing 10 different fluorescent dyes.  By imaging in 9 different channels, each channel a different pairing of excitation wavelength and emission wavelength, each dye can be distinguished by the unique fingerprint of intensities in each channel.  This yields 10 clearly separable labeling schemes. Theoretically 48 different labeling schemes can be distinguished in this way.  One ASHG poster from Countable demonstrated 8-fold multiplexing





So what can you do with so many colors? And with 6 logs of dynamic range?


One poster presented by ASHG focused on BRAF oncogenic mutation detection.  Three clinically relevant mutations are seen at position 600 of the protein: V600E, V600K, and V600R.  By first using 18 cycles of a PCR design agnostic to the status of codon 600 as a pre-amplification and then using allele-specific primers covering the four alleles (three oncogenic variants plus wildtype) and each primer a different color, Countable was able to demonstrate detection of the variants when present in a sample at a frequency of 0.08% - much better than the 1-5% achievable with qPCR and 0.1% for digital PCR.   That’s also not a trivial detection limit to achieve with a sequencing assay - but at about $16 per sample the Countable assay will be far less expensive than any NGS assay unless you can batch to a very high degree.  These results also leverage the high dynamic range of Countable’s assay - detecting between 400 and 700K molecules with a single assay system.  


In another poster, Countable demonstrates measuring mitochondrial genome copy number, using multiple distinguishable probes targeting the mitochondria plus an additional one to get the nuclear genome as a reference.





Countable is also touting that they have built the system for GMP workflows, with the built-in software providing audit trails and other required security features for 21 CFR Part II compliance.  


Another interesting feature of Countable PCR is the ability to recover samples post-amplification - a protocol is provided to extract DNA out of the matrix. So you can count from a precious sample and then potentially fully sequence it as well.


Tuesday, November 11, 2025

Bell Labs Wasn't Built in a Day. Or Two Years.

Rome is famous for persisting for centuries - and having not been built in a day. If you go there, then one of the most magnificent sites is the most famous sporting arena in the world, the Flavian Amphitheater - better known as the Coliseum. Last week there was colossal news in the biotech world that Arena Bioworks was shutting down, after only two years and $100M spent of its "committed' half billion in funding.  What went wrong?

Tuesday, November 04, 2025

Nineteen

If I had been more atop things, I would have written this just under a week ago, on the nineteenth anniversary of my starting to write in this space.  That's a milestone, and actually writing something is the way to try to push back towards some regular frequency in posting here.  But the real reason for the title is something I've mused on a small bit for many of those years: can we shave one amino acid out of the proteome?

Wednesday, October 15, 2025

ASHG Posters: The Agony and The Ecstasy

ASHG is a huge meeting, probably the second largest I've ever attended after ASCO.  ASBMB is similar in size perhaps, though I think a hair smaller and definitely a bigger than ESHG.  And certainly multiple AGBTs in scale.  And that is crashing in on me now.

Tuesday, October 14, 2025

PacBio: $300 Genome Via Chemistry Update

ASHG is here in Boston, just down the street from Ginkgo's HQ.  I'm in a new role in Ginkgo Automation, trying to convince the NGS world that our automation platform is the bee's knees.  So excellent timing.  In advance of the meeting I was able to grab 30 minutes of PacBio CEO Christian Henry's time - last time I saw him he was fresh out of the legendary midnight AGBT  ILMN vs. PACB doubles beer pong match.  Christian gave me a heads up on some of the product news that hit the wires a bit earlier this morning. At the top of that is a new version of the core chemistry, SPRQ-Nx, which boosts yields 10-15% as well as the official launch of flowcell reuse.

Thursday, August 07, 2025

10X Scoops Scale

News broke this afternoon that microfluidics single cell genomics leader 10X Genomics has bought out split-pool single cell company Scale Biosciences for $30 million up front in cash and stock, with additional payments of undisclosed amounts if certain milestones are reached.